Sidharth Chopra
Associate Professor, CSIR
Location: India
Consulting Services
Areas Of Interest
Professional Narrative
Employment
Education
Referees
Publications
https://scholar.google.com/citations?user=OXpp0UYAAAAJ&hl=en
Grants,Awards and Certifications
Grants :
|
SI. No |
Title of the project |
Project Category / CDRI No |
Participating Agencies |
Your role as defined |
|
International GAP Projects |
||||
|
1 |
Target identification and hit-to-lead optimization of SRI-12742 targeting MDR A. baumannii |
GAP0355 |
Indo-German ICMR-BMBF |
PI |
|
2 |
SELECTAR: Selection for antimicrobial resistance by antimicrobial production waste |
GAP0363 |
DBT-NERC Indo-UK |
Co-PI |
|
National GAP Projects |
||||
|
3 |
Small molecule inducers of redox stress targeting antibiotic resistance |
GAP0240 |
DBT |
Co-PI |
|
4 |
Synthesis and therapeutic evaluation of new LpxC inhibitors as potent anti-bacterial agents. |
GAP0246 |
DST |
Co-PI |
|
5 |
Design and Synthesis of Hybrid Molecules for Multi-Drug Resistant Tuberculosis |
GAP0284 |
DBT |
PI |
|
6 |
Novel rationally designed DNA gyrase inhibitors as antibacterials |
GAP0285 |
DBT |
PI |
|
7 |
Therapeutic evaluation of organometallic compounds as antibacterial agents |
GAP0291 |
DST |
Co-PI |
|
8 |
Repurposing Oxiconazole: Alone and in combination with PUFA's as a broad spectrum antibacterial |
GAP0310 |
DBT |
PI |
|
9 |
Screening of Phytochemical and Bioactive compounds against human pathogenic bacteria of selected indigenous medicinal plants of Arunachal Pradesh, India |
GAP0311 |
DBT |
Co-PI |
|
10 |
Probing sp³-rich spirocyclic scaffolds in drug discovery: Syntheses of Cyanogramide, FR901483 and their diversified analogues towards leads against Mtb and ESKAPE pathogen |
GAP0320 |
DST |
Co-PI |
|
11 |
Structure-activity validation of inhibitors of bacterial peptidyl-tRNA hydrolase for tackling AMR |
GAP0328 |
DBT |
Co-PI |
|
12 |
Development of candidate RL348 for methicillin- and vancomycin-resistant Staphylococcus aureus |
GAP0332 |
DBT |
Co-PI |
|
13 |
A cocktail of phages effective against urinary tract infections caused by biofilm forming MDR uropathogenic E. coli |
GAP0333 |
DBT |
Co-PI |
|
14 |
Synergistic Metal-based Antimicrobial Agents for AMR Bacterial Pathogens: Combinatorial and Multimodal Approach |
GAP0360 |
ICMR |
Co-PI |
Awards & Prizes :
- Novozymes A/S: Awarded $88,000 for Post-doctoral Research at Stanford University School of Medicine
- Council for Scientific and Industrial Research, India (CSIR)-UGC-NET Fellowship: Awarded fellowship for pursuing doctoral studies
